GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Intermolecular Inc (NAS:IMI) » Definitions » Operating Margin %

Intermolecular (Intermolecular) Operating Margin % : -119.16% (As of Jun. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Intermolecular Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Intermolecular's Operating Income for the three months ended in Jun. 2019 was $-5.50 Mil. Intermolecular's Revenue for the three months ended in Jun. 2019 was $4.62 Mil. Therefore, Intermolecular's Operating Margin % for the quarter that ended in Jun. 2019 was -119.16%.

The historical rank and industry rank for Intermolecular's Operating Margin % or its related term are showing as below:


IMI's Operating Margin % is not ranked *
in the Semiconductors industry.
Industry Median: 4.425
* Ranked among companies with meaningful Operating Margin % only.

Intermolecular's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Intermolecular's Operating Income for the three months ended in Jun. 2019 was $-5.50 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2019 was $-11.86 Mil.


Intermolecular Operating Margin % Historical Data

The historical data trend for Intermolecular's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intermolecular Operating Margin % Chart

Intermolecular Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.27 -45.73 -31.19 -25.95 -12.92

Intermolecular Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 -11.85 -45.58 -38.20 -119.16

Competitive Comparison of Intermolecular's Operating Margin %

For the Semiconductor Equipment & Materials subindustry, Intermolecular's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intermolecular's Operating Margin % Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, Intermolecular's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Intermolecular's Operating Margin % falls into.



Intermolecular Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Intermolecular's Operating Margin % for the fiscal year that ended in Dec. 2018 is calculated as

Operating Margin %=Operating Income (A: Dec. 2018 ) / Revenue (A: Dec. 2018 )
=-4.348 / 33.66
=-12.92 %

Intermolecular's Operating Margin % for the quarter that ended in Jun. 2019 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2019 ) / Revenue (Q: Jun. 2019 )
=-5.503 / 4.618
=-119.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intermolecular  (NAS:IMI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Intermolecular Operating Margin % Related Terms

Thank you for viewing the detailed overview of Intermolecular's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intermolecular (Intermolecular) Business Description

Traded in Other Exchanges
N/A
Address
3011 North First Street, San Jose, CA, USA, 95134
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Executives
Raging Capital Management, Llc 10 percent owner TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228
Christian Kramer director, officer: President and CEO 6 DAVIS AVE APT B22, RYE NY 10580
Irwin Federman 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Kenneth H Traub director
William C Martin 10 percent owner C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553
Bill Roeschlein officer: Chief Financial Officer C/O SELECTICA, INC., 3 WEST PLUMERIA, SAN JOSE CA 95134
George Scalise director
Marvin D Burkett director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Redpoint Ventures Ii, L.p. 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Associates Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Ventures Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Neil S Subin other: Former 10% Owner 2336 S.E. OCEAN BOULEVARD, #400, STUART FL 34996
Presidio Management Group Ix, L.l.c. 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Steven M Krausz 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
U S Venture Partners Ix L P 10 percent owner 2735 SAND HILL RD, MENLO PARK CA 94025

Intermolecular (Intermolecular) Headlines

From GuruFocus

Intermolecular Sets December 2018 Financial Conference Schedule

By PRNewswire PRNewswire 11-27-2018